PMCB PharmaCyte Biotech, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$0.55
Price · Aug 17, 2026
Fundamentals as of Jul 29, 2026
52W Range
$1–$2
2% of range
Analyst Rating
HOLD
6 analysts
Price Target
—
P/E (TTM)
-0.2
ROE
-56.7%
Net Profit Margin
—

PMCB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.55
Market Cap
$6M
P/E (TTM)
-0.2
EPS (TTM)
$-2.77
Revenue (TTM)
$0
Div Yield
—
ROE
-56.7%
Debt/Equity
—
52W Range
$1 – $2

PMCB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $0
Flat — no change across 10 periods
2017-04-30 → 2026-04-30
EPS $-2.77
6-point trend, -13.1%
2021-04-30 → 2026-04-30
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
PMCB
Peer Median
P/E (TTM)
5-point trend, +97.0%
-0.2
—
P/B
5-point trend, +465.0%
0.2
1.0

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
PMCB
Peer Median
ROA
5-point trend, -340.7%
-38.1%
-105.1%
ROE
5-point trend, -1111.3%
-56.7%
-142.1%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
PMCB
Peer Median
Current Ratio
5-point trend, -62.7%
45.3
1.6
Quick Ratio
5-point trend, -81.2%
22.8
—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
PMCB
Peer Median
Net Income YoY
5-point trend, -358.2%
9085.0%
—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
PMCB
Peer Median
EPS (Diluted)
5-point trend, -925.9%
$-2.77
—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
PMCB
Peer Median

PMCB Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

SELL 6 analysts
  • Strong Buy 0 0.0%
  • Buy 0 0.0%
  • Hold 3 50.0%
  • Sell 1 16.7%
  • Strong Sell 2 33.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Next Report
Sep 14, 2026
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.09 — —
Sept. 30, 2025 $-0.10 — —
June 30, 2025 $-0.29 — —
March 31, 2025 $0.14 — —

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
PMCB $8M -0.3 — — -56.7% —
ERNA — — — — — —
ENSC $4M -0.2 -2.8% -200.9% -294.0% —
BOLT $11M -0.3 0.07% -433.7% -102.2% —
CDIO — — — — — —
ACXP $6M -0.5 — — -180.3% —
BRTX $10M -0.7 -10.3% -3959.4% -547.6% 93.4%
XBIO — -1.4 19.0% — — —
DRMA — — — — — —
GOVX $296.2K — -37.1% -862.3% -645.9% —
LABT — — — — — —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16
Annual Income Statement data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
Revenue Flat — no change across 12 periods $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Cost of Revenue Flat — no change across 2 periods · · · · · · · · · · $0 $0
Gross Profit Flat — no change across 2 periods · · · · · · · · · · $0 $0
R&D Expense 12-point trend, -88.7% $391.3K $438.4K $407.4K $468.5K $690.9K $916.2K $301.2K $460.1K $2M $1M $1M $3M
SG&A Expense 12-point trend, +127.3% $5M $4M $6M $1M $1M $418.1K $1M $1M $2M $744.8K $2M $2M
Operating Expenses 12-point trend, -48.3% $7M $4M $9M $6M $4M $4M $4M $4M $7M $4M $6M $13M
Operating Income 12-point trend, +48.3% $-7M $-4M $-9M $-6M $-4M $-4M $-4M $-4M $-7M $-4M $-6M $-13M
Interest Expense 9-point trend, -100.0% · · · $0 $509 $3.0K $453 $0 $0 $1.5K $1.2K $4.9K
Other Non-op 12-point trend, -100.0% $-980 $-965 $191.1K $202.0K $-4.3K $71.7K $-493 $33.4K $152.6K $-1.5K $9.3K $3M
Income Tax Flat — no change across 12 periods $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income 12-point trend, -95.7% $-19M $31M $333.8K $-4M $-4M $-4M $-4M $-4M $-7M $-4M $-6M $-10M
EPS (Basic) 6-point trend, -13.1% $-2.77 $3.19 $-1.80 $-0.22 $-0.27 $-2.45 · · · · · ·
EPS (Diluted) 6-point trend, -13.1% $-2.77 $3.19 $-1.80 $-0.22 $-0.27 $-2.45 · · · · · ·
Shares (Basic) 12-point trend, -98.8% 8,378,291 7,329,596 9,581,059 19,489,204 15,521,654 1,448,285 903,812 1,100,104,338 968,641,686 845,308,413 752,403,049 704,327,656
Shares (Diluted) 12-point trend, -98.8% 8,378,291 7,329,596 9,581,059 19,489,204 15,521,654 1,448,285 903,812 1,100,104,338 968,641,686 845,308,413 752,403,049 704,327,656
EBITDA 11-point trend, -12.9% $-7M $-4M $-9M $-6M $-4M $-4M $-4M $-4M $-7M $-4M $-6M ·
Balance Sheet 19
Annual Balance Sheet data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
Cash & Equivalents 12-point trend, +589.1% $19M $15M $50M $68M $85M $2M $894.9K $515.3K $1M $3M $2M $3M
Short-term Investments 3-point trend, +254010.00 $254.0K $366.3K $0 · · · · · · · · ·
Prepaid Expense 12-point trend, -93.4% $96.9K $223.8K $259.8K $107.7K $94.2K $73.1K $142.8K $138.2K $224.1K $74.3K $110.0K $1M
Current Assets 12-point trend, +797.8% $37M $22M $50M $68M $85M $2M $1M $653.4K $1M $4M $2M $4M
Intangibles 5-point trend, -100.0% $0 $2M $2M $4M $4M · · · · · · ·
Other Non-current Assets 9-point trend, -2.1% $7.7K $7.7K · · · $7.4K $7.4K $7.4K $7.4K $7.4K $7.9K $7.9K
Total Assets 12-point trend, +402.9% $47M $55M $60M $73M $91M $7M $6M $6M $6M $9M $7M $9M
Accounts Payable 12-point trend, -45.4% $271.1K $399.2K $389.4K $128.3K $205.4K $172.3K $185.8K $121.9K $352.6K $365.6K $336.0K $496.7K
Accrued Liabilities 12-point trend, +2109.1% $522.8K $3M $735.2K $458.3K $499.0K $552.5K $816.6K $621.0K $291.5K $214.6K $151.6K $23.7K
Current Liabilities 12-point trend, -45.6% $826.4K $3M $7M $586.6K $704.4K $724.8K $1M $742.9K $644.2K $580.2K $637.6K $2M
Total Liabilities 12-point trend, +674.3% $12M $3M $20M $586.6K $704.4K $724.8K $1M $742.9K $644.2K $580.2K $637.6K $2M
Common Stock 12-point trend, -96.4% $2.6K $2.2K $2.2K $2.2K $2.1K $159 $109 $118.6K $101.3K $90.5K $78.1K $73.3K
Paid-in Capital 12-point trend, +111.6% $183M $181M $185M $202M $202M $114M $109M $105M $102M $97M $91M $86M
Retained Earnings 12-point trend, -32.8% $-104M $-85M $-116M $-116M $-112M $-107M $-104M $-100M $-96M $-89M $-85M $-79M
Treasury Stock 5-point trend, +45009541.00 $45M $45M $42M $14M $0 · · · · · · ·
AOCI 12-point trend, -1522.4% $-20.8K $-23.9K $-23.5K $-23.0K $-15.8K $-20.4K $-21.7K $-13.8K $-4.7K $1.7K $806 $1.5K
Stockholders' Equity 12-point trend, +328.1% $33M $52M $28M $73M $90M $7M $5M $5M $6M $8M $7M $8M
Liabilities + Equity 12-point trend, +402.9% $47M $55M $60M $73M $91M $7M $6M $6M $6M $9M $7M $9M
Shares Outstanding 12-point trend, -98.5% 10,735,649 6,795,779 8,037,624 16,793,980 20,721,047 1,590,084 1,092,425 1,186,004,505 1,013,260,644 905,349,047 781,233,338 732,760,536
Cash Flow 9
Annual Cash Flow data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
Stock-based Comp 12-point trend, +21.4% $892.5K $0 $674.7K $7.3K $33.1K $194.3K $368.6K $293.3K $580.4K $420.5K $405.1K $735.2K
Operating Cash Flow 12-point trend, -13.0% $-5M $-3M $-2M $-4M $-4M $-3M $-2M $-3M $-5M $-3M $-4M $-5M
Investing Cash Flow 10-point trend, +2000000.00 $2M $-7M $-5M $0 $0 $0 $0 $0 $0 $0 · ·
Stock Issued 9-point trend, -100.0% · · · $0 $87M $5M $3M $2M $3M $5M $4M $4M
Stock Repurchased 5-point trend, +401625.00 $401.6K $3M $28M $14M $0 · · · · · · ·
Net Stock Activity 11-point trend, -111.3% $-401.6K $-3M $-28M $-14M $87M $5M $3M $2M $3M $5M $4M ·
Financing Cash Flow 10-point trend, +34.8% $7M $-25M $-11M $-14M $87M $5M $3M $2M $3M $5M · ·
Net Change in Cash 7-point trend, +804.0% $3M $-35M $-18M $-17M $83M $1M $379.6K · · · · ·
Taxes Paid 10-point trend, -100.0% $0 $0 $1.6K $0 $1.6K $800 $800 $800 $800 $800 · ·
Profitability 2
Annual Profitability data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
ROA 11-point trend, +48.3% -38.1% 53.3% 0.50% -5.3% -8.6% -52.3% -64.0% -66.7% -90.6% -56.1% -73.7% ·
ROE 11-point trend, +33.2% -56.7% 66.5% 1.1% -5.8% -4.7% -49.7% -81.3% -78.2% -117.7% -60.8% -84.8% ·
Liquidity & Solvency 3
Annual Liquidity & Solvency data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
Current Ratio 11-point trend, +1321.7% 45.3 7.7 6.8 116.2 121.4 3.1 1.0 0.9 2.0 6.1 3.2 ·
Quick Ratio 11-point trend, +657.5% 22.8 5.3 6.8 116.0 121.2 3.0 0.9 0.7 1.6 6.0 3.0 ·
Interest Coverage 5-point trend, -69.2% · · · · -8628.7 -1189.4 -8446.8 · · -2886.4 -5099.2 ·
Efficiency 1
Annual Efficiency data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
Asset Turnover Flat — no change across 11 periods 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ·
Per Share 5
Annual Per Share data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
Book Value / Share 11-point trend, +37265.1% $3.10 $7.64 $3.44 $4.33 $56.55 $4.20 $0.00 $0.00 $0.01 $0.01 $0.01 ·
Revenue / Share Flat — no change across 11 periods $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ·
Cash Flow / Share 11-point trend, -10503.4% $-0.61 $-0.41 $-0.22 $-0.19 $-0.27 $-2.30 $-0.00 $-0.00 $-0.01 $-0.00 $-0.01 ·
Cash / Share 11-point trend, +69216.0% $1.73 $2.23 $6.24 $4.05 $53.71 $1.38 $0.00 $0.00 $0.00 $0.00 $0.00 ·
EPS (TTM) 6-point trend, -13.1% $-2.77 $3.19 $-1.80 $-0.22 $-0.27 $-2.45 · · · · · ·
Growth Rates 1
Annual Growth Rates data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
Net Income YoY · 9085.0% · · · · · · · · · ·
Valuation (TTM) 8
Annual Valuation (TTM) data for PMCB
Metric Trend 202620252024202320222021202020192018201720162015
Revenue TTM Flat — no change across 12 periods $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income TTM 12-point trend, -95.7% $-19M $31M $333.8K $-4M $-4M $-4M $-4M $-4M $-7M $-4M $-6M $-10M
Market Cap 11-point trend, -100.0% $8M $8M $17M $49M $4M $44M $62.23B $75.37B $84.81B $109.32B $82.95B ·
P/E 6-point trend, +97.7% -0.3 0.4 -1.2 -13.3 -8.6 -11.2 · · · · · ·
P/B 11-point trend, -100.0% 0.2 0.2 0.6 0.7 0.0 6.5 12227.9 14955.8 14701.8 13517.1 12716.8 ·
P / Tangible Book 7-point trend, -100.0% 0.2 0.2 0.7 0.7 0.0 6.5 12227.9 · · · · ·
P / Cash Flow 11-point trend, +100.0% -1.5 -2.8 -7.9 -12.9 -0.9 -13.1 -26611.4 -26189.3 -16696.9 -32734.7 -19084.1 ·
Earnings Yield 6-point trend, -4196.3% -383.7% 257.3% -84.9% -7.5% -11.6% -8.9% · · · · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2026-04-302025-04-302024-04-302023-04-302022-04-30
Revenue $0$0$0$0$0
Net Income $-19M$31M$333.8K$-4M$-4M
Diluted EPS $-2.77$3.19$-1.80$-0.22$-0.27
Balance Sheet
2026-04-302025-04-302024-04-302023-04-302022-04-30
Current Ratio 45.37.76.8116.2121.4
Quick Ratio 22.85.36.8116.0121.2

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 37 filers · $649K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
5 (-4 vs prior Q) 5 (+1 vs prior Q) 3 (-3 vs prior Q) 10 (+4 vs prior Q) -204K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
CITADEL ADVISORS LLC $218,203 283,381 33.62% Shares
GEODE CAPITAL MANAGEMENT, LLC $80,235 104,187 12.36% Shares
CITADEL ADVISORS LLC $66,297 86,100 10.22% Call option
VANGUARD CAPITAL MANAGEMENT LLC $43,719 56,778 6.74% Shares
VANGUARD GROUP INC $37,262 51,467 5.74% Shares
RENAISSANCE TECHNOLOGIES LLC $29,250 37,987 4.51% Shares
XTX Topco Ltd $26,319 34,180 4.06% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $25,994 33,759 4.01% Shares
NORTHERN TRUST CORP $25,120 32,624 3.87% Shares
Schonfeld Strategic Advisors LLC $20,733 26,926 3.19% Shares
JANE STREET GROUP, LLC $20,470 26,585 3.15% Shares
VANGUARD FIDUCIARY TRUST CO $18,058 23,452 2.78% Shares
EQUITEC PROPRIETARY MARKETS, LLC $17,115 22,227 2.64% Shares
COMMONWEALTH EQUITY SERVICES, LLC $15,600 20,255 2.40% Shares
Tower Research Capital LLC (TRC) $3,764 4,888 0.58% Shares
GROUP ONE TRADING LLC $385 500 0.06% Shares
OSAIC HOLDINGS, INC. $231 302 0.04% Shares
BARCLAYS PLC $148 192 0.02% Shares
UBS Group AG $23 30 0.00% Shares
Sachetta, LLC $11 14 0.00% Shares
HRT FINANCIAL LP $11 15,451 0.00% Shares
SBI Securities Co., Ltd. $5 6 0.00% Shares
BFSG, LLC $4 5 0.00% Shares
CoreCap Advisors, LLC $3 4 0.00% Shares
CALDWELL SUTTER CAPITAL, INC. $2 2 0.00% Shares
HARBOUR INVESTMENTS, INC. $2 3 0.00% Shares
FINANCIAL CONSULATE, INC $2 2 0.00% Shares
NewEdge Advisors, LLC $2 2 0.00% Shares
Johnson Financial Group, Inc. $1 1 0.00% Shares
MCF Advisors LLC $1 1 0.00% Shares
MORGAN STANLEY $1 1 0.00% Shares
BlackRock, Inc. $1 1 0.00% Shares
Abound Wealth Management $1 1 0.00% Shares
Accredited Wealth Management, LLC $1 50 0.00% Shares
CWM, LLC $1 1 0.00% Shares
Covestor Ltd $0 275 0.00% Shares
HUNTINGTON NATIONAL BANK $0 1 0.00% Shares

Company insiders 4 insiders · 0 officers · 4 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Michael M Abecassis Director March 31, 2026 J — 0 0 $0
Jonathan Schechter Director March 31, 2026 J — 0 0 $0
Wayne Remell Walker Director March 31, 2026 J — 0 0 $0
Robert Weinstein Director March 31, 2026 J — 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 3 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
PharmaCyte Biotech, Inc. ×2 filings Nov. 18, 2025 74.00% Amendment — SEC
Iroquois Master Fund Ltd., Iroquois Capital Management, LLC, Iroquois Capital Investment Group LLC, Richard Abbe, Kimberly Page ×6 filings June 16, 2023 — Initial filing — SEC
Nima Montazeri (1) 2 (a) (b), Silver Rock Associates, Inc. (1) 2 (a) (b), Brown Stone Capital, LP (1) 2 (a) (b) ×2 filings July 29, 2020 — Initial filing — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 56,778 SH Aug. 8, 2026 Daily